Radiological Imaging of Tuberculosis and Human Immunodefi ciency Virus

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


It is estimated that billion people around the world are infected with tuberculosis (TB). The immune system alterations suffered by patients with human immunodeficiency virus (HIV) infection make them highly susceptible to developing TB disease. The use of isoniazid preventive therapy (IPT) has been shown to be effective in reducing the TB risk in both individuals infected with HIV and those not infected. Imaging studies of patients with suspected pulmonary disease associated with retroviral infection must start with conventional radiography. The other imaging studies include computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)/CT. The follow-up of patients being treated for TB is essentially clinical. Imaging follow-up is limited to patients with high risk of relapse, patients treated for some multiresistant infections and patients who did not complete treatment due to drug toxicity.

Original languageEnglish
Title of host publicationDiagnostic Imaging of Infections and Inflammatory Diseases
Subtitle of host publicationA Multidisciplinary Approach
Number of pages12
ISBN (Electronic)9781118484388
ISBN (Print)9781118484418
StatePublished - 15 Jul 2013
Externally publishedYes


  • Computed tomography (CT)
  • Human immunodeficiency virus
  • Isoniazid preventive therapy (IPT)
  • Magnetic resonance imaging (MRI)
  • Positron emission tomography (PET)
  • Tuberculosis


Dive into the research topics of 'Radiological Imaging of Tuberculosis and Human Immunodefi ciency Virus'. Together they form a unique fingerprint.

Cite this